"Adenocarcinoma, Mucinous" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An adenocarcinoma producing mucin in significant amounts. (From Dorland, 27th ed)
Descriptor ID |
D002288
|
MeSH Number(s) |
C04.557.470.200.025.075 C04.557.470.590.075
|
Concept/Terms |
Adenocarcinoma, Mucinous- Adenocarcinoma, Mucinous
- Adenocarcinomas, Mucinous
- Mucinous Adenocarcinoma
- Mucinous Adenocarcinomas
- Carcinoma, Colloid
- Carcinomas, Colloid
- Colloid Carcinoma
- Colloid Carcinomas
- Carcinoma, Mucinous
- Carcinomas, Mucinous
- Mucinous Carcinoma
- Mucinous Carcinomas
|
Below are MeSH descriptors whose meaning is more general than "Adenocarcinoma, Mucinous".
Below are MeSH descriptors whose meaning is more specific than "Adenocarcinoma, Mucinous".
This graph shows the total number of publications written about "Adenocarcinoma, Mucinous" by people in this website by year, and whether "Adenocarcinoma, Mucinous" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 1 | 0 | 1 |
1995 | 1 | 0 | 1 |
1997 | 0 | 1 | 1 |
1998 | 3 | 2 | 5 |
1999 | 2 | 1 | 3 |
2000 | 1 | 2 | 3 |
2001 | 1 | 0 | 1 |
2002 | 3 | 0 | 3 |
2003 | 2 | 0 | 2 |
2004 | 6 | 1 | 7 |
2005 | 7 | 3 | 10 |
2006 | 7 | 6 | 13 |
2007 | 6 | 3 | 9 |
2008 | 4 | 2 | 6 |
2009 | 3 | 3 | 6 |
2010 | 6 | 1 | 7 |
2011 | 9 | 1 | 10 |
2012 | 4 | 1 | 5 |
2013 | 6 | 3 | 9 |
2014 | 6 | 3 | 9 |
2015 | 8 | 1 | 9 |
2016 | 4 | 0 | 4 |
2017 | 6 | 0 | 6 |
2018 | 9 | 0 | 9 |
2019 | 9 | 1 | 10 |
2020 | 5 | 0 | 5 |
2021 | 2 | 0 | 2 |
2022 | 6 | 0 | 6 |
2023 | 5 | 2 | 7 |
2024 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Adenocarcinoma, Mucinous" by people in Profiles.
-
Mucinous Rectal Adenocarcinoma-Challenges in Magnetic Resonance Imaging Interpretation. J Comput Assist Tomogr. 2024 Sep-Oct 01; 48(5):683-692.
-
Investigating the Spatial Distribution of Proliferating Cells in Primary Ovarian Cancers. Discov Med. 2024 Mar; 36(182):632-645.
-
Repeat Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Mucinous Appendiceal Adenocarcinoma: A Viable Treatment Strategy with Demonstrable Benefit. Ann Surg Oncol. 2024 Jan; 31(1):614-621.
-
A Practical Strategy to Reduce Surgical Overtreatment of Intraductal Papillary Mucinous Neoplasms of the Pancreas. Ann Surg. 2024 Jul 01; 280(1):32-34.
-
Intraperitoneal Paclitaxel Is a Safe and Effective Therapeutic Strategy for Treating Mucinous Appendiceal Adenocarcinoma. Cancer Res. 2023 10 02; 83(19):3184-3191.
-
HER2/ ERBB2 Immunohistochemical Expression and Copy Number Status in Ovarian Mucinous Tumors. Int J Gynecol Pathol. 2024 Mar 01; 43(2):134-139.
-
Uptake and Outcomes of Neoadjuvant Chemotherapy Among US Patients With Less Common Epithelial Ovarian Carcinomas. JAMA Netw Open. 2023 06 01; 6(6):e2318602.
-
Efficacy of Systemic Chemotherapy in Patients With Low-grade Mucinous Appendiceal Adenocarcinoma: A Randomized Crossover Trial. JAMA Netw Open. 2023 06 01; 6(6):e2316161.
-
Secondary Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy for Advanced or Recurrent Mucinous Ovarian Cancer. Obstet Gynecol. 2023 05 01; 141(5):1019-1023.
-
Recurrent Neuroendocrine Primary Cutaneous Mucinous Carcinoma of the Scalp After Complete Excision. Am J Dermatopathol. 2023 Feb 01; 45(2):123-126.